Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Larrey

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
The Annals of Pharmacotherapy|April 23, 2009
Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitisHélène Peyrière, Ludmilla Tatem, Camille Bories, et al.
Annals of Hepatology|June 6, 2019
Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life studyVictor de Ledinghen, Bertrand Hanslik, Joseph Moussalli, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
Use of human hepatocytes to investigate HCV infectionLydiane Pichard-Garcia, Philippe Briolotti, Dominique Larrey, et al.
Drug Safety|February 22, 2011
Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgeryPaul B Watkins, Mehul Desai, Scott D Berkowitz, et al.
Drug Safety|March 24, 2005
Hepatic findings in long-term clinical trials of ximelagatranWilliam M Lee, Dominique Larrey, Rolf Olsson, et al.
The Annals of Pharmacotherapy|November 22, 2013
Acute hepatitis and renal failure related to intranasal buprenorphine misuse: case report and analysis of cases reported to the French network for drug monitoringCéline Eiden, Marie-Pierre Ripault, Dominique Larrey, et al.
JHEP Reports : Innovation in Hepatology|July 4, 2024
CDK4/6 inhibitor-induced liver injury: Clinical phenotypes and role of corticosteroid treatmentLucy Meunier, Eleonora De Martin, Bénédicte Delire, et al.
Antiviral Therapy|May 22, 2012
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirinDominique Larrey, Christophe Carenco, Dominique Guyader, et al.
Annals of Hepatology|April 29, 2004
Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trialDiego García-Compean, Pierre Blanc, Dominique Larrey, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Journal of Clinical Lipidology|October 7, 2020
Long-term safety and efficacy of lomitapide in patients with homozygous familial hypercholesterolemia: Five-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)James A Underberg, Christopher P Cannon, Dominique Larrey, et al.
The Annals of Pharmacotherapy|April 23, 2009
Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitisHélène Peyrière, Ludmilla Tatem, Camille Bories, et al.
Annals of Hepatology|June 6, 2019
Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life studyVictor de Ledinghen, Bertrand Hanslik, Joseph Moussalli, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 21, 2010
Use of human hepatocytes to investigate HCV infectionLydiane Pichard-Garcia, Philippe Briolotti, Dominique Larrey, et al.
Drug Safety|February 22, 2011
Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgeryPaul B Watkins, Mehul Desai, Scott D Berkowitz, et al.
Drug Safety|March 24, 2005
Hepatic findings in long-term clinical trials of ximelagatranWilliam M Lee, Dominique Larrey, Rolf Olsson, et al.
The Annals of Pharmacotherapy|November 22, 2013
Acute hepatitis and renal failure related to intranasal buprenorphine misuse: case report and analysis of cases reported to the French network for drug monitoringCéline Eiden, Marie-Pierre Ripault, Dominique Larrey, et al.
JHEP Reports : Innovation in Hepatology|July 4, 2024
CDK4/6 inhibitor-induced liver injury: Clinical phenotypes and role of corticosteroid treatmentLucy Meunier, Eleonora De Martin, Bénédicte Delire, et al.
Antiviral Therapy|May 22, 2012
Sustained virological response after 14-day treatment with danoprevir and 48-week treatment with pegylated interferon-α2a (40 KD) plus ribavirinDominique Larrey, Christophe Carenco, Dominique Guyader, et al.
Annals of Hepatology|April 29, 2004
Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trialDiego García-Compean, Pierre Blanc, Dominique Larrey, et al.
Pageof 14